To compare the effect of pancreatic β cells protection, Kimura et al. [56] found that both GLP-1 agonists, Liraglutide and pioglitazone, preserved the function and mass of β cells, although this action was more profound during the early compared to advance stages in T2DM in db/db mice. The gene discussed is GCG; the disease is type 2 diabetes mellitus.